[Bio Protocol Secures $6.9 Million in Funding, Led by Maelstrom Fund] Decentralized science platform Bio Protocol announced the completion of a $6.9 million funding round, led by Maelstrom Fund, with participation from Mechanism Capital, Animoca Brands, Presto Labs, and others. This round of funding coincides with the launch of Bio V2, introducing on-chain fundraising, a decentralized AI scientific research framework, and the incentive system BioXP. BioAgents, serving as decentralized scientific AI agents, enable researchers and the community to generate hypotheses, fund experiments, and monetize discoveries. The first BioAgent went live in August in collaboration with VitaDAO and the Aubrey de Grey Lab, generating over $250,000 in research funding and more than a thousand longevity hypotheses.